HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research by Pietrantonio, F., Caporale, M., Morano, F., Scartozzi, M., Gloghini, A., De Vita, F., Giommoni, E., Fornaro, L., Aprile, G., Melisi, D., Berenato, R., Mennitto, A., Volpi, C. C., Laterza, M. M., Pusceddu, V., Antonuzzo, L., Vasile, E., Ongaro, E., Simionato, F., de Braud, F., Torri, V., Di Bartolomeo, M.

Get full text

Role of molecular genetics in the clinical management of cholangiocarcinoma by Normanno, N., Martinelli, E., Melisi, D., Pinto, C., Rimassa, L., Santini, D., Scarpa, A.

Get full text

Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials by Merz, V, Messina, C, Zecchetto, C, Quinzii, A, Frisinghelli, M, Trentin, C, Salati, M, Caffo, O, Melisi, D

Get full text

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients by Piro, G, Giacopuzzi, S, Bencivenga, M, Carbone, C, Verlato, G, Frizziero, M, Zanotto, M, Mina, M M, Merz, V, Santoro, R, Zanoni, A, De Manzoni, G, Tortora, G, Melisi, D

Get full text

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling by Carbone, C, Piro, G, Gaianigo, N, Ligorio, F, Santoro, R, Merz, V, Simionato, F, Zecchetto, C, Falco, G, Conti, G, Kamga, P T, Krampera, M, Di Nicolantonio, F, De Franceschi, L, Scarpa, A, Tortora, G, Melisi, D

Get full text

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort by Peretti, U., Cavaliere, A., Niger, M., Tortora, G., Di Marco, M.C., Rodriquenz, M.G., Centonze, F., Rapposelli, I.G., Giordano, G., De Vita, F., Stuppia, L., Avallone, A., Ratti, M., Paratore, C., Forti, L.G., Orsi, G., Valente, M.M., Gaule, M., Macchini, M., Carrera, P., Calzavara, S., Simbolo, M., Melisi, D., De Braud, F., Salvatore, L., De Lorenzo, S., Chiarazzo, C., Falconi, M., Cascinu, S., Milella, M., Reni, M.

Get full text

Prognostic role of early nutritional support in patients affected by advanced pancreatic cancer undergoing chemotherapy by Trestini, I., Carbognin, L., Sperduti, I., Bonaiuto, C., Auriemma, A., Melisi, D., Salvatore, L., Giorgetti, G., Bria, E., Tortora, G.

Get full text

Impact of pancreatic enzyme replacement therapy (PERT) on survival in patients affected by advanced pancreatic ductal adenocarcinoma (PDAC) undergoing first-line chemotherapy by Trestini, I., Carbognin, L., Peretti, U., Sperduti, I., Caldart, A., Melisi, D., Auriemma, A., Soldà, C., Tregnago, D., Avancini, A., Pilotto, S., Bria, E., Tortora, G., Reni, M., Milella, M.

Get full text

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202 by Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G.M., Melisi, D., Al Rajabi, R.M., Paulson, A.S., Borad, M.J., Gallinson, D., Murphy, A.G., Oh, D.-Y., Dotan, E., Catenacci, D.V., Van Cutsem, E., Lihou, C.F., Zhen, H., Veronese, M.L., Abou-Alfa, G.K.

Get full text

Clinical impact of sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT) by Trestini, I., Paiella, S., Sandini, M., Hank, T., Pollini, T., Sperduti, I., Melisi, D., Auriemma, A., Soldà, C., Tregnago, D., Avancini, A., Lanza, M., Malleo, G., D'onofrio, M., Gianotti, L., Pilotto, S., Salvia, R., Del Castillo, C., Bassi, C., Milella, M.

Get full text

Radiation detectors based on Multiwall Carbon Nanotubes deposited by a spray technique by Melisi, D., Nitti, M.A., Valentini, M., Valentini, A., Ditaranto, N., Cioffi, N., Di Franco, C.

Get full text

Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life... by Giordano, G, Lo Re, G, Milella, M, Di Marco, M, Melisi, D, Passardi, A, Iop, A, Febbraro, A, Foltran, L, Francesca, B, Bertocchi, P, Vaccaro, V, Aloi, M.B, Giommoni, E, Ricci, V, Vasile, E, Zaniboni, A, Zagone, V, De Vita, F

Get full text

248 Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patients by Piro, G, Carbone, C, Cataldo, I, Di Nicolantonio, F, Giacopuzzi, S, Boschi, F, Zanotto, M, Merz, V, Mina, M.M, Sbarbati, A, De Manzoni, G, Scarpa, A, Tortora, G, Melisi, D

Get full text

Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement by Rimassa, Lorenza, Brandi, Giovanni, Niger, Monica, Normanno, Nicola, Melisi, Davide

Get full text

2357 Prognostic factors in 709 advanced gastric cancer patients exposed to second-line therapy by Fontanella, C, Fanotto, V, Uccello, M, Vasile, E, Bozzarelli, S, Filippi, R, Santini, D, Rosati, G, Tomasello, G, Silvestris, N, Pietrantonio, F, Bergamo, F, Cinieri, S, Melisi, D, Antonuzzo, L, Fornaro, L, Cordio, S, Pasquini, G, Rimassa, L, Aprile, G

Get full text

2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts) by Giordano, G, De Vita, F, Melisi, D, Vaccaro, V, Zaniboni, A, Zagonel, V, Vasile, E, Passardi, A, Leo, L, Ventriglia, J, Marciano, R, Russano, M, Conca, R, Andreozzi, F, Lucchini, E, Musettini, G, Bertocchi, P, Bergamo, F, Milella, M, Febbraro, A

Get full text

2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian “real life” study by Giordano, G, Febbraro, A, Vaccaro, V, Zagonel, V, De Giorgi, U, Melisi, D, Vasile, E, Bianco, R, Lo Re, G, Valente, M, Formica, V, Montesarchio, V, Maiorino, L, Sanna, G, Bittoni, A, Ricci, V, Santini, D, Zaniboni, A, Milella, M, De Vita, F

Get full text

Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity by Catauro, M., Melisi, D., Curcio, A., Rimoli, M.G.

Get full text

Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples High-Exci... by Ruocco, L.A., Gironi Carnevale, U.A., Treno, C., Sadile, A.G., Melisi, D., Arra, C., Ibba, M., Schirru, C., Carboni, E.

Get full text

Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats by Ruocco, L.A, Viggiano, D, Viggiano, A, Abignente, E, Rimoli, M.G, Melisi, D, Curcio, A, Nieddu, M, Boatto, G, Carboni, E, Gironi Carnevale, U.A, Sadile, A.G

Get full text